Asia Digest: NatureSelect.ai raises over $100m; Aulis Capital closes debut $200m fund

Résumé détaillé

Chinese AI emotional companion startup NatureSelect.ai has attracted more than $100 million in new financing, while ex-Qiming managing partner Nisa Leung’s Aulis Capital has…

Chinese AI emotional companion startup NatureSelect.ai has attracted more than $100 million in new financing, while ex-Qiming managing partner Nisa Leung’s Aulis Capital has reached the final closing of its inaugural fund.

Shenzhen-based startup NatureSelect.ai, which develops artificial intelligence (AI) emotional companion products, has raised more than $100 million in new financing ahead of a new product launch this month.

5Y Capital, Qiming Venture Partners, SCV, iMPC and HyT Capital backed NatureSelect.ai in the new financing.

Founded in early 2024, NatureSelect.ai develops AI-driven experiences promoting long-term human-AI relationships. Its key products include EVE, a 3D AI companion equipped with long-term memory. Beyond text, voice, and video interactions, EVE can proactively execute real-world tasks, such as ordering boba tea or flower deliveries, bridging virtual companionship with everyday life for users.

The startup is also developing Elys, an agentic social network where user interactions naturally generate contextual memory. Leveraging this data, personalised AI avatars can help users surface high-value insights, build meaningful connections, and explore new experiences across the platform.

Since its launch of Elys in private beta this February, the startup has made progress in optimising the multi-user social memory system, while enhancing privacy protection and improving connection efficiency. Currently, the latest version of Elys remains in invite-only beta testing, with the official version expected to launch this month.

The startup counts BAI Capital, Ubiquant Partners, Eastern Bell Capital, and HSG among its early backers.

Aulis Capital, a young investment firm led by ex-Qiming managing partner Nisa Leung, has reached the final closing of its inaugural fund, Aulis Capital Fund I, L.P., with total capital commitments of $200 million.

Founded in October 2025, Aulis Capital targets early- and growth-stage companies across the life sciences and healthcare…

Début de l'article, extrait de DealStreetAsia. Pour lire la suite, ouvrez l'article chez le média.